Compass Biotechnologies Company Top Insiders

Compass Biotechnologies Management Team Effectiveness

The company has return on total asset (ROA) of (0.0336) % which means that it has lost $0.0336 on every $100 spent on assets. This is way below average. Compass Biotechnologies' management efficiency ratios could be used to measure how well Compass Biotechnologies manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -6.33. The Compass Biotechnologies' current Return On Capital Employed is estimated to increase to -5.05. As of now, Compass Biotechnologies' Total Current Assets are increasing as compared to previous years. The Compass Biotechnologies' current Fixed Asset Turnover is estimated to increase to 648.03, while Total Assets are projected to decrease to under 95.5 K. The current Net Loss is estimated to decrease to about (391 K)

Compass Biotechnologies Workforce Comparison

Compass Biotechnologies Benchmark Summation

Compass Biotechnologies Notable Stakeholders

The success or failure of an entity such as Compass Biotechnologies often depends on how effective the management is. Compass Biotechnologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Compass management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Compass management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Compass Biotechnologies' price analysis, check to measure Compass Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Biotechnologies is operating at the current time. Most of Compass Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Compass Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Biotechnologies' price. Additionally, you may evaluate how the addition of Compass Biotechnologies to your portfolios can decrease your overall portfolio volatility.